Abiopharma

🔍 Advaithi Revathi (Director)

Company: FLEX LTD. (FLEX)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Sold 35,051 shares of Ordinary Shares (Direct)
  Date: 2026-08-18 | Code: J | equity_swap_involved: 0 | shares_owned_after: 117,857.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By GRAT | shares_owned_after: 815,262.00
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By GRAT I | shares_owned_after: 215,685.00 | Footnotes: F4
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By GRAT II | shares_owned_after: 215,685.00 | Footnotes: F5

Footnotes:

• F1: Reflects a transfer by the Reporting Person of 35,051 directly owned ordinary shares to an irrevocable trust that was established for the benefit of the Reporting Person's children for which the Reporting Person is a grantor, in satisfaction of her obligations to such trust under a $4,376,143.09 promissory note.
• F2: Includes the following: (1) 54,739 unvested restricted share units ("RSUs"), which will vest on June 12, 2027; and (2) 63,117 unvested RSUs, which will vest in two equal annual installments beginning on June 12, 2027.
• F3: Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited.
• F4: Reflects the transfer by the Reporting Person of 215,685 directly owned ordinary shares to a grantor retained annuity trust ("GRAT I"), which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act.
• F5: Reflects the transfer by the Reporting Person of 215,685 directly owned ordinary shares to a grantor retained annuity trust ("GRAT II"), which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act.